Skip to main content

Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)

Publication ,  Conference
Wood, WA; Deal, AM; Reeve, BB; Abernethy, AP; Battaglini, CL; Kim, YH; Whitley, JS; Shatten, C; Irons, RN; Essenmacher, AN; Wehner, K ...
Published in: Blood
November 16, 2012

Abstract 4471

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 16, 2012

Volume

120

Issue

21

Start / End Page

4471 / 4471

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wood, W. A., Deal, A. M., Reeve, B. B., Abernethy, A. P., Battaglini, C. L., Kim, Y. H., … Shea, T. C. (2012). Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT). In Blood (Vol. 120, pp. 4471–4471). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.4471.4471
Wood, William A., Allison M. Deal, Bryce B. Reeve, Amy P. Abernethy, Claudio L. Battaglini, Yoon Hie Kim, Julia S. Whitley, et al. “Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT).” In Blood, 120:4471–4471. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.4471.4471.
Wood WA, Deal AM, Reeve BB, Abernethy AP, Battaglini CL, Kim YH, et al. Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT). In: Blood. American Society of Hematology; 2012. p. 4471–4471.
Wood, William A., et al. “Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT).” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 4471–4471. Crossref, doi:10.1182/blood.v120.21.4471.4471.
Wood WA, Deal AM, Reeve BB, Abernethy AP, Battaglini CL, Kim YH, Whitley JS, Shatten C, Irons RN, Essenmacher AN, Wehner K, Pinto A, Coghill J, Armistead PM, Sarantopoulos S, Gabriel DA, Serody JS, Shea TC. Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT). Blood. American Society of Hematology; 2012. p. 4471–4471.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 16, 2012

Volume

120

Issue

21

Start / End Page

4471 / 4471

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology